An in-depth look to JAMJOOM PHARMACEUTICALS FACTORY CO. operating, investing, and financing activities

4015 free cash flow for Q3 24 is 76.88 M SAR. For 2023, 4015 free cash flow was 250.85 M SAR and operating cash flow was 296.03 M SAR.